Massimo Poidomani

Efficacy of caspofungin as secondary prophylaxis in patients undergoing allogeneic stem cell transplantation with prior pulmonary and/or systemic fungal infection

Paolo de Fabritiis, Alessandra Spagnoli, Paolo Di Bartolomeo et al. · Bone Marrow Transplantation · 2007 · 49 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +14

Feasibility, Tolerability and Efficacy of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma Network

Concetta Conticello, Alessandra Romano, Vittorio Del Fabro et al. · Journal of Clinical Medicine · 2019 · 27 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Early measurement of CD34+ cells in peripheral blood after cyclophosphamide and granulocyte colony-stimulating factor treatment predicts later CD34+ mobilisation failure and is a possible criterion for guiding "on demand" use of plerixafor.

Giuseppe Milone, Giovanni Tripepi, Massimo Martino et al. · PubMed · 2013 · 16 citations

Medicine, Hematology, Pharmacotherapy +13

Daratumumab as Single Agent in Relapsed/Refractory Myeloma Patients: A Retrospective Real-Life Survey

Uroš Markovic, Alessandra Romano, Vittorio Del Fabro et al. · Frontiers in Oncology · 2021 · 12 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Prognostic value of CD34+ peak in peripheral blood during mobilization in intermediate-risk AML patients treated in first CR by autologous or allogeneic transplantation

Giuseppe Milone, Massimo Poidomani, Salvatore Leotta et al. · Bone Marrow Transplantation · 2011 · 10 citations · Full text

Medicine, Hematology, Oncology +10